Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14.
about
Characterization, Molecular Docking, and In Vitro Dissolution Studies of Solid Dispersions of 20(S)-Protopanaxadiol.Formulation of ketotifen fumarate fast-melt granulation sublingual tablet.Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug.Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexesInterest of multifunctional lipid excipients: case of Gelucire 44/14.Novel drug delivery approaches on antiviral and antiretroviral agents.Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept.Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility.Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications.Technology evaluation: Kollicoat IR.Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach.Solvent-free melting techniques for the preparation of lipid-based solid oral formulations.Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers.The role of the carrier in the formulation of pharmaceutical solid dispersions. Part I: crystalline and semi-crystalline carriers.Pharmaceutical development and optimization of azithromycin suppository for paediatric use.In vitro dissolution study of atorvastatin binary solid dispersion.Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose.Improved dissolution of oleanolic acid with ternary solid dispersions.Preparation and in vitro evaluation of solid dispersions of total flavones of Hippophae rhamnoides L.Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity.Physicochemical properties of solid dispersions of gliclazide in polyvinylpyrrolidone K90.Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity.Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000.Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique.The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions.Physiochemical Characterization and Release Rate Studies of SolidDispersions of Ketoconazole with Pluronic F127 and PVP K-30.Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization.Development and characterization of a lovastatin-loaded self-microemulsifying drug delivery system.Novel pepper extract for enhanced P-glycoprotein inhibition.Solid state properties of pure UC-781 and solid dispersions with polyvinylpyrrolidone (PVP K30).Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent.Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract.The effect of homogenization method on the properties of carbamazepine microparticles prepared by spray congealing.Pharmacokinetics of UC781-loaded intravaginal ring segments in rabbits: a comparison of polymer matrices.Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000.Lean Raman imaging for rapid assessment of homogeneity in pharmaceutical formulations.Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
P2860
Q31162573-6951513C-7133-46F7-B7A3-5AD8241C533CQ33985935-8C111406-284E-44E1-93AB-25909C71FA77Q33986048-68A51E03-DB88-4A88-9F6A-0D7E9C685990Q35219316-B1FB0422-AC7F-4335-AD8E-45AFF488FF52Q36181538-A1F10EE5-31CF-4133-83AA-6DB5A887C24FQ36234508-B1C1F174-3707-4B97-98C4-67BF64F4E98FQ36283306-26DC9214-6CCF-4398-8553-D702F9C6730AQ36882074-CAC45DAB-0549-4030-ADAF-BCD7A08A0B6FQ37703241-F53A385B-720E-45B2-881D-4CD2DDF4832DQ37826428-41CB87DE-CAE0-41E7-BBA7-C448B520A203Q37854665-8C676A75-2E02-4CF6-9E95-A8369B5ECFB1Q38257177-CF6D0120-030F-4C60-80B4-627A5B844640Q38383531-429F5327-10FA-4BBF-88C0-376C2541DED1Q38411322-548953BE-51BB-4382-8350-64FD2160D17AQ38856754-CFD29FFA-31E0-4190-A2E4-33C09C0E69A8Q38870191-F7914F38-EC2E-468E-99CB-623F8A9C3769Q39124475-15756DAF-53D1-42F4-93D8-86BCE4230AD5Q40432062-11280181-8BC5-4DAA-8019-52CB9B9D23BAQ41725344-E57ED2DA-2E57-4CD9-B54D-54958514890DQ41916465-BDF524FB-1008-467D-8EA4-AFACC50D442AQ41952701-629B69EE-7946-4BF4-89F0-DC64677912F9Q41961437-C91034D8-A1DF-4B9F-8626-6275BE17FCB0Q41973412-B8D3127D-1A0C-4A11-8CE2-03909B0C8B63Q41987467-9414C39C-ACCC-46C4-A314-7C5A67097994Q41989600-991B0090-2743-417D-AA28-6B492E884B57Q41990256-6AF42917-12C0-4135-A545-E25424C7FB4AQ42927321-47D981D6-E9D5-4795-A51F-83697A7A4CB7Q42927794-E43D6483-E8F5-44F1-99D7-AAB5380D9EC0Q43149705-8CD6D2A2-6C53-49BD-963F-5447150A72B3Q43269122-9E43D4F0-1717-42E8-9DA8-09F3D265FAD4Q43287004-75C311A4-401F-48AB-936A-D9423B46241FQ43716401-6A7329EE-594B-4E89-B8C0-99E04F13334DQ43844886-69151191-6CD7-4CD4-8651-2F0FA5395C3BQ44193644-571FA3C9-31DB-43BB-97A6-93A154368ACEQ44597484-C0E73E51-8EC0-4439-970E-A87AD0A29759Q45010869-9BCB0926-52E1-4F56-8EA4-153F315D3D74Q45260301-41A217C2-8B76-40E0-B809-A11D98EA2093Q46040749-C102EC45-0CB5-48C6-9029-3A4429FD77E8Q46065850-7A602108-1093-4437-8DBD-44DD3BDBE298Q46418404-00D023B9-ACB0-475C-B449-DE445DEE0AE9
P2860
Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Physicochemical characterizati ...... lycol 6000 and Gelucire 44/14.
@en
type
label
Physicochemical characterizati ...... lycol 6000 and Gelucire 44/14.
@en
prefLabel
Physicochemical characterizati ...... lycol 6000 and Gelucire 44/14.
@en
P2093
P1476
Physicochemical characterizati ...... lycol 6000 and Gelucire 44/14.
@en
P2093
Augustijns P
Balzarini J
Van den Mooter G
P304
P356
10.1016/S0928-0987(00)00084-1
P407
P577
2000-01-01T00:00:00Z